• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫组织浸润的分泌抗体细胞的异质性。

Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues.

机构信息

Department of Pathology, Grenoble University Hospital, Grenoble, France.

Translational Research in Autoimmunity and Inflammation Group (TRAIG), Translational Innovation in Medicine and Complexity (TIMC), University Grenoble-Alpes, CNRS Unité mixte de recherche (UMR) 5525, Grenoble, France.

出版信息

Front Immunol. 2023 Feb 21;14:1111366. doi: 10.3389/fimmu.2023.1111366. eCollection 2023.

DOI:10.3389/fimmu.2023.1111366
PMID:36895558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9989216/
Abstract

The humoral response is frequently dysfunctioning in autoimmunity with a frequent rise in total serum immunoglobulins, among which are found autoantibodies that may be pathogenic by themselves and/or propagate the inflammatory reaction. The infiltration of autoimmune tissues by antibody-secreting cells (ASCs) constitutes another dysfunction. The known high dependency of ASCs on the microenvironment to survive combined to the high diversity of infiltrated tissues implies that ASCs must adapt. Some tissues even within a single clinical autoimmune entity are devoid of infiltration. The latter means that either the tissue is not permissive or ASCs fail to adapt. The origin of infiltrated ASCs is also variable. Indeed, ASCs may be commonly generated in the secondary lymphoid organ draining the autoimmune tissue, and home at the inflammation site under the guidance of specific chemokines. Alternatively, ASCs may be generated locally, when ectopic germinal centers are formed in the autoimmune tissue. Alloimmune tissues with the example of kidney transplantation will also be discussed own to their high similarity with autoimmune tissues. It should also be noted that antibody production is not the only function of ASCs, since cells with regulatory functions have also been described. This article will review all the phenotypic variations indicative of tissue adaptation described so for at the level of ASC-infiltrating auto/alloimmune tissues. The aim is to potentially define tissue-specific molecular targets in ASCs to improve the specificity of future autoimmune treatments.

摘要

体液免疫反应在自身免疫中经常出现功能障碍,总血清免疫球蛋白经常升高,其中存在自身抗体,自身抗体本身可能具有致病性和/或引发炎症反应。自身抗体分泌细胞 (ASC) 浸润自身免疫组织是另一种功能障碍。已知 ASC 高度依赖微环境才能存活,加上浸润组织的高度多样性,这意味着 ASC 必须适应。即使在单一的临床自身免疫实体中,某些组织也没有浸润。后者意味着要么组织不允许浸润,要么 ASC 无法适应。浸润 ASC 的起源也是可变的。事实上,ASC 可能通常在引流自身免疫组织的次级淋巴器官中产生,并在特定趋化因子的引导下归巢到炎症部位。或者,当自身免疫组织中形成异位生发中心时,ASC 也可以在局部产生。同种异体组织(例如肾移植)也将被讨论,因为它们与自身免疫组织具有高度相似性。还应该注意的是,抗体产生不是 ASC 的唯一功能,因为也已经描述了具有调节功能的细胞。本文将综述迄今为止在 ASC 浸润的自身/同种免疫组织水平上描述的所有表明组织适应的表型变化。目的是潜在地定义 ASC 中的组织特异性分子靶标,以提高未来自身免疫治疗的特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c74/9989216/14a418c6ea42/fimmu-14-1111366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c74/9989216/14a418c6ea42/fimmu-14-1111366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c74/9989216/14a418c6ea42/fimmu-14-1111366-g001.jpg

相似文献

1
Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues.自身免疫组织浸润的分泌抗体细胞的异质性。
Front Immunol. 2023 Feb 21;14:1111366. doi: 10.3389/fimmu.2023.1111366. eCollection 2023.
2
Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.原发性硬化性胆管炎和原发性胆汁性胆管炎中肝内浸润 B 细胞的表型和自身抗体产生。
J Autoimmun. 2017 Feb;77:45-54. doi: 10.1016/j.jaut.2016.10.003. Epub 2016 Oct 24.
3
Immunoregulation by antibody secreting cells in inflammation, infection, and cancer.抗体分泌细胞在炎症、感染和癌症中的免疫调节作用。
Immunol Rev. 2021 Sep;303(1):103-118. doi: 10.1111/imr.12991. Epub 2021 Jun 17.
4
MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic for Sle1 and Human CD19.MEDI-551 治疗可有效耗竭 SLE1 转基因和人 CD19 转基因小鼠的 B 细胞并降低血清自身抗体滴度。
Arthritis Rheumatol. 2016 Apr;68(4):965-76. doi: 10.1002/art.39503.
5
Targeting BMI-1 to deplete antibody-secreting cells in autoimmunity.靶向BMI-1以清除自身免疫中的抗体分泌细胞。
Clin Transl Immunology. 2023 Oct 4;12(10):e1470. doi: 10.1002/cti2.1470. eCollection 2023.
6
CD19-positive antibody-secreting cells provide immune memory.CD19 阳性抗体分泌细胞提供免疫记忆。
Blood Adv. 2018 Nov 27;2(22):3163-3176. doi: 10.1182/bloodadvances.2017015172.
7
Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome.唇腺中分泌抗体的细胞特异性反映了干燥综合征患者的临床表现和血清学特征。
Arthritis Rheumatol. 2014 Dec;66(12):3445-56. doi: 10.1002/art.38872.
8
Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.自身免疫性神经疾病中的短期和长期分泌自身抗体的细胞。
Front Immunol. 2021 Jun 17;12:686466. doi: 10.3389/fimmu.2021.686466. eCollection 2021.
9
Differentiation and homing of IgA-secreting cells.分泌IgA细胞的分化与归巢。
Mucosal Immunol. 2008 Mar;1(2):96-109. doi: 10.1038/mi.2007.14. Epub 2008 Jan 23.
10
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.

引用本文的文献

1
Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome.探索增殖诱导配体(APRIL)在自身免疫中的作用:对系统性红斑狼疮、类风湿关节炎和干燥综合征治疗靶点的启示
Front Immunol. 2025 Aug 1;16:1523392. doi: 10.3389/fimmu.2025.1523392. eCollection 2025.

本文引用的文献

1
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.抗 CD19 CAR T 细胞疗法治疗难治性系统性红斑狼疮。
Nat Med. 2022 Oct;28(10):2124-2132. doi: 10.1038/s41591-022-02017-5. Epub 2022 Sep 15.
2
Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma.开发高亲和力诱饵受体治疗多发性骨髓瘤和弥漫性大 B 细胞淋巴瘤。
J Exp Med. 2022 Sep 5;219(9). doi: 10.1084/jem.20220214. Epub 2022 Jul 26.
3
Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis.
单细胞和空间转录组学整合分析揭示早期类风湿关节炎关节中的自身反应性分化 B 细胞。
Sci Rep. 2022 Jul 13;12(1):11876. doi: 10.1038/s41598-022-15293-5.
4
What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?失败、中断和撤回的多发性硬化症抗体疗法给我们带来了什么启示?
Neurotherapeutics. 2022 Apr;19(3):785-807. doi: 10.1007/s13311-022-01246-3. Epub 2022 Jul 6.
5
Bruton's Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and Perspectives.用于治疗免疫性疾病的布鲁顿激酶抑制剂:现状与展望
J Clin Med. 2022 May 16;11(10):2807. doi: 10.3390/jcm11102807.
6
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?新冠病毒疫苗接种后的血清转化:我们能否优化 CD20 治疗个体的保护反应?
Clin Exp Immunol. 2022 May 12;207(3):263-271. doi: 10.1093/cei/uxab015.
7
Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.TACI 的配体非依赖性寡聚化受跨膜结构域控制,并调节活化 B 细胞的增殖。
Cell Rep. 2022 Mar 29;38(13):110583. doi: 10.1016/j.celrep.2022.110583.
8
Daratumumab for treatment-refractory antibody-mediated diseases in neurology.达雷妥尤单抗用于治疗难治性神经科抗体介导疾病。
Eur J Neurol. 2022 Jun;29(6):1847-1854. doi: 10.1111/ene.15266. Epub 2022 Feb 10.
9
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.皮下注射伊纳鲁单抗(VAY736)治疗原发性干燥综合征患者的安全性和有效性:一项随机、双盲、安慰剂对照的2b期剂量探索试验。
Lancet. 2022 Jan 8;399(10320):161-171. doi: 10.1016/S0140-6736(21)02251-0. Epub 2021 Nov 30.
10
CXCL12/SDF-1 in IgG4-Related Disease.IgG4相关疾病中的CXCL12/SDF-1
Front Pharmacol. 2021 Oct 26;12:750216. doi: 10.3389/fphar.2021.750216. eCollection 2021.